MarketPeel
Insider Trading Intelligence
Pricing
…
PB

Paul D. Burgess

KLRA
SEE REMARKS · KAILERA THERAPEUTICS, INC. · CIK 0001744627
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Apr 2026
HOLDINGS NOW
100,000
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Paul D. Burgess. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
KLRA
KAILERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
100,000——100,000Apr 16, 2026Apr 20, 2026 ↗
Other insiders · KLRA
Loading peer insiders…
About this filer
CIK 0001744627
ROLE
See Remarks
PRIMARY
KLRA
COMPANIES
1
ACTIVE SINCE
Apr 2026
MARKETPEEL · /INSIDER/0001744627DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback